137076-54-1

Basic information

• Product Name: TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD
• Synonyms: 2-[4,7,10-tris[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid;(4,7,10-Tris-tert-butoxycarbonylmethyl-1,4,7,10tetraaza-cyclododec-1-yl)-acetic acid;Tri-tert-butyl 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetate;DOTA-tris(tert-butyl ester) Novabiochem;1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7-tris(1,1-dimethylethyl) ester;TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD;TRI-TERT-BUTYL 1,4,7,10-TETRAAZACYCLODODECANE-TETRAACETATE;1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-acetic acid
• CAS NO: 137076-54-1
• Molecular Formula: C₂₈H₅₂N₄O₈
• Molecular Weight: 572.73448
• Mol File: 137076-54-1.mol

Chemical Properties

• Melting Point: 129-131℃
• Boiling Point: 632.127 °C at 760 mmHg
• Flash Point: 336.099 °C
• Appearance: /
• Density: 1.079
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.48
• Storage Temp.: Store at +2°C to +8°C.
• Solubility: Aqueous Base (Slightly), Chloroform (Slightly), DMSO (Slightly),Methanol (Slight
• PKA: 4.24±0.10(Predicted)
• CAS DataBase Reference: TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD(CAS DataBase Reference)
• NIST Chemistry Reference: TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD(137076-54-1)
• EPA Substance Registry System: TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD(137076-54-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 137076-54-1(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 137076-54-1 differently. You can refer to the following data:
1. DOTA-tris (t-Bu ester), is a Bifunctional chelator, that can be used in the preparation of gadolinium complexes as MRI blood contrast agents.
2. Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (tri BOC-DOTA) can be employed as a reactant to prepare: Gadolinium ion functionalized with DOTA-LAE (lactobionic acid-ethylenediamine), which is used as a contrast agent for magnetic resonance imaging (MRI). DOTA-conjugates of ursolic acid and ZD2 peptide 64Cu-DOTA conjugates.

InChI:InChI=1/C28H52N4O8/c1-26(2,3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4,5)6)15-17-32(16-14-30)21-25(37)40-28(7,8)9/h10-21H2,1-9H3,(H,33,34)

Upstream product

• 10045-25-7 1,4,7,10-tetraazacyclododecane tetrahydrochloride 
• 107-59-5 tert-Butyl chloroacetate 
• 468743-81-9 1-[1-(ethoxycarbonyl)methyl]-1,4,7,10-tetraazacyclododecane 
• 1412494-55-3 C₃₁H₅₆N₄O₈ 
• 1023970-58-2 (1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid allyl ester 
• 294-90-6 1,4,7,10-tetraazacyclododecan 
• 173308-18-4 tri-tert-butyl 2,2',2''-(10-(2-methoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
• 825625-07-8 tri-tert-butyl 2,2’,2’‘-(10-(2-ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
• 67-56-1 methanol 
• 79-08-3 bromoacetic acid 
• 122555-91-3 1,4,7-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane 
• 244219-73-6 (1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid benzyl ester 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 192635-89-5 phenylmethyl 2-(1,4,7,10-Tetraaza-4,7,10-tris(((tert-butyl)oxycarbonyl)methyl)cyclododecyl)-acetate 

Downstream Products

• 170908-81-3 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(N-hydroxysuccinimidyl ester) 
• 277330-12-8 N-[carbo(2,3,5,6-tetrafluorophenoxy)methyl]-1,4,7,10-tetraazacyclododecane-N',N'',N'''-triacetic acid tri-tert-butyl ester 
• 508172-23-4 DOTA(tert-Bu)3-Boc-L-Lys-OMe 
• 1268342-46-6 Gd(N₄C₈H₁₆(CH₂COO)3CH₂CONH(CH₂)3OC₆H₃C₂HCOOC₆H₄N(CH₃)2) 
• 1334397-05-5 tert-butyl 2,2',2''-(10-(2-oxo-2-(16-(2-oxo-2-((4-((4-propoxyphenyl)ethynyl)pyridin-2-yl)methylamino)ethyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecan-7-yl)ethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
• 60239-18-1 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane 
• 75-65-0 tert-butyl alcohol 
• 1412494-59-7 C₃₇H₆₂N₆O₈ 

Relevant articles and documents

Solid-Phase Assisted N-1 Functionalization of Azamacrocycles

A simple solid-phase assisted strategy for the N-1 functionalization of azamacrocycles is described. Compounds such as cyclen, cyclam and piperazine can be selectively modified by temporary attachment to solid-phase resins providing an efficient and clean method to prepare biomedically interesting moieteies.

Cyclin A probes by means of intermolecular sensitization of terbium-chelating peptides

Intermolecular sensitization of lanthanide ions was effectively implemented in the development of fluorescent sensors targeting cyclin A. A chelating unit has been conjugated to peptides containing a known cyclin A binding motif (CBM). Upon interaction of the modified terbium-chelating peptides with the cyclin A substrate recruitment groove, the Tb3+ ion is placed in the vicinity of the Trp217 side chain, which results in efficient intermolecular terbium sensitization and specific long wavelength fluorescent emission from the metal center. Copyright

Design, synthesis, and in vitro evaluation of a binary targeting MRI contrast agent for imaging tumor cells

A binary targeting vector that consists of peptide sequences of Arg-Gly-Asp (RGD) and Asn-Gly-Arg (NGR) motifs has been designed and synthesized using solid-phase peptide synthesis procedure. The vector is then coupled with Gd-DOTA to work as a targeting

Synthesis and characterisation of a novel tubulin-directed DO3A-colchicine conjugate with potential theranostic features

Colchicine is a known tubulin binding agent enabling necrosis in tumors. A novel tubulin-directed DO3A-colchicine conjugate and its Gd(III) complex were prepared from N-deacetylcolchicine, coupling alkaloid and polyaza-alicyclic functions via a peptide coupling methodology. The longitudinal proton relaxivity of the Gd(III) complex in water at 4.7 T is 2.86 mM-1 s-1 and a similar efficacy as colchicine towards ovarian carcinoma cells in vitro.

Multimodal image-guided enzyme/prodrug cancer therapy

The conjugate of bacterial cytosine deaminase (bCD) and poly-l-lysine (PLL) that was functionalized with biotin, rhodamine, and Gd3+-DOTA was synthesized and characterized. It demonstrated high relaxivity, improved enzymatic specificity to prodrug 5-fluorocytosine, low cytotoxicity, efficient cell uptake, and high enzymatic stability in fresh mouse serum and human breast cancer cell culture. Copyright

Fine-tuning the pH trigger of self-assembly

The creation of smart, self-assembling materials that undergo morphological transitions in response to specific physiological environments can allow for the enhanced accumulation of imaging or drug delivery agents based on differences in diffusion kinetics. Here, we have developed a series of self-assembling peptide amphiphile molecules that transform either isolated from molecules or spherical micelles into nanofibers when the pH is slightly reduced from 7.4 to 6.6, in isotonic salt solutions that simulate the acidic extracellular microenvironment of malignant tumor tissue. This transition is rapid and reversible, indicating the system is in thermodynamic equilibrium. The self-assembly phase diagrams show a single-molecule-to-nanofiber transition with a highly concentration-dependent transition pH. However, addition of a sterically bulky Gd(DO3A) imaging tag on the exterior periphery shifts this self-assembly to more acidic pH values and also induces a spherical micellar morphology at high pH and concentration ranges. By balancing the attractive hydrophobic and hydrogen-bonding forces, and the repulsive electrostatic and steric forces, the self-assembly morphology and the pH of transition can be systematically shifted by tenths a pH unit.

Development of a dual functional luminescent sensor for zinc ion based on a peptidic architecture

A synthetic peptide bearing a lanthanide complex, TbOTZ exhibits a decrease of chromophore fluorescence and a concomitant luminescence enhancement due to sensitized Tb3+ upon Zn2+ binding. Thus, TbOTZ can be a valuable tool for ratiometric sensing of Zn2+ as well as for time-resolved fluorescence detection with a single molecule.

Time-Resolved Terbium-Based Probe for the Detection of Zinc(II) Ions: Investigation of the Formation of a Luminescent Ternary Complex

Because of their unique photochemical and photophysical properties, luminescent lanthanide-based complexes have long captivated chemists. In recent years, the number of reports of luminescent lanthanide complex-based probes for monitoring of biological an

Photoresponsive host-guest chemistry and relaxation time of fluorinated cyclodextrin and T1=T* 2 arylazopyrazole-functionalized DOTA metal complexes

Light-responsive modulation of the longitudinal (T1) and transversal T *2) relaxation times of a fluorinated cyclodextrin has been achieved by host-guest complexation with arylazopyrazole-modified metal complexes in aqueous solution. This supramolecular concept can potentially be applied to the development of contrast agents for19F magnetic resonance imaging (MRI).

Ligand taking indocyanine green derivative as carrier as well as preparation method and application of ligand

The invention discloses a ligand taking an indocyanine green derivative as a carrier as well as a preparation method and application of the ligand. When the ligand is chelated with paramagnetic metal ions, an NIR/MRI multi-mode contrast agent is obtained, when the ligand is chelated with radioactive metal ions, an NIR/PET multi-mode contrast agent is obtained, and the obtained contrast agents can be used for diagnosis of various tumors, especially liver cancer. Meanwhile, the contrast agents are good in water solubility and low in toxicity, mutual verification of multiple contrast modes is achieved, diagnosis information is enriched, diagnosis precision is improved, and a feasible novel contrast agent is provided for early diagnosis of tumors clinically.